For research use only. Not for therapeutic Use.
Bambuterol(Cat No.:I004966) is a long-acting prodrug of the beta-2 adrenergic agonist terbutaline, primarily used as a bronchodilator for the management of asthma and chronic obstructive pulmonary disease (COPD). After oral administration, Bambuterol is slowly converted into terbutaline, which acts on beta-2 adrenergic receptors in the lungs, leading to bronchodilation and relief from bronchospasm. The gradual conversion of the drug allows for prolonged effects, providing lasting control of asthma symptoms with a once-daily dosing regimen. Bambuterol is known for its efficacy in improving airway function and its ability to reduce symptoms in patients with respiratory disorders, making it a valuable therapeutic option in respiratory care.
Catalog Number | I004966 |
CAS Number | 81732-65-2 |
Molecular Formula | C18H29N3O5 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | in DMSO > 10 mM |
Storage | Store at -20°C |
IUPAC Name | [3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate |
InChI | InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3 |
InChIKey | ANZXOIAKUNOVQU-UHFFFAOYSA-N |
SMILES | CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O |